| pubmed-article:6137651 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6137651 | lifeskim:mentions | umls-concept:C0023418 | lld:lifeskim |
| pubmed-article:6137651 | lifeskim:mentions | umls-concept:C0026764 | lld:lifeskim |
| pubmed-article:6137651 | lifeskim:mentions | umls-concept:C0025241 | lld:lifeskim |
| pubmed-article:6137651 | lifeskim:mentions | umls-concept:C0348016 | lld:lifeskim |
| pubmed-article:6137651 | pubmed:issue | 8354 | lld:pubmed |
| pubmed-article:6137651 | pubmed:dateCreated | 1983-11-23 | lld:pubmed |
| pubmed-article:6137651 | pubmed:abstractText | 1 previously untreated patient with plasma-cell leukaemia and 8 patients with myeloma (4 previously untreated) were treated with high-dose melphalan 100-140 mg/m2 iv. All responded to treatment. 3 of the 5 previously untreated patients achieved biochemical and bone-marrow complete remissions. | lld:pubmed |
| pubmed-article:6137651 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6137651 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6137651 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:6137651 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6137651 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6137651 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6137651 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:6137651 | pubmed:issn | 0140-6736 | lld:pubmed |
| pubmed-article:6137651 | pubmed:author | pubmed-author:McElwainT JTJ | lld:pubmed |
| pubmed-article:6137651 | pubmed:author | pubmed-author:PowlesR LRL | lld:pubmed |
| pubmed-article:6137651 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6137651 | pubmed:day | 8 | lld:pubmed |
| pubmed-article:6137651 | pubmed:volume | 2 | lld:pubmed |
| pubmed-article:6137651 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6137651 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6137651 | pubmed:pagination | 822-4 | lld:pubmed |
| pubmed-article:6137651 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:6137651 | pubmed:meshHeading | pubmed-meshheading:6137651-... | lld:pubmed |
| pubmed-article:6137651 | pubmed:meshHeading | pubmed-meshheading:6137651-... | lld:pubmed |
| pubmed-article:6137651 | pubmed:meshHeading | pubmed-meshheading:6137651-... | lld:pubmed |
| pubmed-article:6137651 | pubmed:meshHeading | pubmed-meshheading:6137651-... | lld:pubmed |
| pubmed-article:6137651 | pubmed:meshHeading | pubmed-meshheading:6137651-... | lld:pubmed |
| pubmed-article:6137651 | pubmed:meshHeading | pubmed-meshheading:6137651-... | lld:pubmed |
| pubmed-article:6137651 | pubmed:meshHeading | pubmed-meshheading:6137651-... | lld:pubmed |
| pubmed-article:6137651 | pubmed:meshHeading | pubmed-meshheading:6137651-... | lld:pubmed |
| pubmed-article:6137651 | pubmed:meshHeading | pubmed-meshheading:6137651-... | lld:pubmed |
| pubmed-article:6137651 | pubmed:meshHeading | pubmed-meshheading:6137651-... | lld:pubmed |
| pubmed-article:6137651 | pubmed:meshHeading | pubmed-meshheading:6137651-... | lld:pubmed |
| pubmed-article:6137651 | pubmed:meshHeading | pubmed-meshheading:6137651-... | lld:pubmed |
| pubmed-article:6137651 | pubmed:meshHeading | pubmed-meshheading:6137651-... | lld:pubmed |
| pubmed-article:6137651 | pubmed:meshHeading | pubmed-meshheading:6137651-... | lld:pubmed |
| pubmed-article:6137651 | pubmed:meshHeading | pubmed-meshheading:6137651-... | lld:pubmed |
| pubmed-article:6137651 | pubmed:year | 1983 | lld:pubmed |
| pubmed-article:6137651 | pubmed:articleTitle | High-dose intravenous melphalan for plasma-cell leukaemia and myeloma. | lld:pubmed |
| pubmed-article:6137651 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:6137651 | pubmed:publicationType | Case Reports | lld:pubmed |
| pubmed-article:6137651 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6137651 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6137651 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6137651 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6137651 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6137651 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6137651 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6137651 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6137651 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6137651 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6137651 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6137651 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6137651 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6137651 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6137651 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6137651 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6137651 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6137651 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6137651 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6137651 | lld:pubmed |
